Temasek invests in Romsons Group to fuel India medical device expansion

Temasek Holdings has taken a strategic minority investment in Romsons Group, one of India's prominent medical devices manufacturers, marking the sovereign wealth fund's latest move to back healthcare-focused businesses in the region. The investment will provide capital to accelerate Romsons' expansion plans within India while also supporting the company's international growth objectives across key markets in South and Southeast Asia.

The funding will enable Romsons to explore strategic acquisitions and consolidation opportunities within the fragmented medical devices sector, where scale and technological capabilities have become increasingly important for competitive positioning. The partnership reflects Temasek's continued focus on backing mid-sized Indian healthcare companies positioned to benefit from rising domestic consumption and regulatory improvements.

Romsons Group manufactures a diverse portfolio of medical and surgical devices, serving hospitals, clinics and retailers across India. The company has established itself as a significant player in the domestic market, with operations spanning manufacturing, distribution and retail channels. The Temasek investment is expected to strengthen Romsons' financial capacity to pursue organic growth initiatives and inorganic expansion through targeted acquisitions.

For Temasek, the investment aligns with its long-standing strategy of backing high-growth sectors across Asia, particularly healthcare and medical technology businesses that benefit from demographic trends and rising healthcare spending in the region.